Please contact us for more information or to learn if you are eligible to participate.
The purpose is to evaluate the efficacy, safety, and tolerability of subcutaneous (SC) inclisiran injection(s) in patients with atherosclerotic cardiovascular disease and elevated LDL – C (Bad Cholesterol)
Mahesh Changlani, MD
The Medicines Comapany
Type of Trial